ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

In Brief: Gregory Curt May Return As Director Of COP; Koop Locked In as Surgeon General Until Nov.

January 20, 1989

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995